Gilead Sciences Inc. – Filings and Transcripts

NASDAQ: GILD
Share price (6/11/26): $125.87
Market cap (6/11/26): $156 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of securities for employees

Third party tender offer – amended

Ownership Filter

Cain Wettan Keeley M

Mercier Johanna

O'Day Daniel Patrick

Dickinson Andrew D

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Other Events, Financial Statements or Exhibits

Announces First Quarter Financial Results

Shareholder Vote Results, Financial Statements or Exhibits

Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-Cel

To Acquire Arcellx to Maximize Long-Term Potential of Anito-Cel

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Annual report of proxy voting record

Letter to shareholders

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC